Disc Medicine, Inc.
NASDAQ:IRONBiotechnology
-$0.02 today
- Market cap
- $2.99B
- Beta
- 2.10
- P/E (TTM)
- -11.2
- EPS (TTM)
- -$6.28
Volume 0.95M
Average 0.47M
IRON Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Disc Medicine, Inc.NASDAQ: IRON
Other Current Liabilities · Q3 FY2026 · quarter ended Sep 2026
Other current liabilities remains negative
Q3 FY2026 other current liabilities was $0, compared with $9M a year earlier. Over 3 fiscal years it compounded at +95.4% a year.
Context
- Other current liabilities amounted to 0.0% of total assets at the end of Q3 FY2026, down 1.4 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 27.01M USD
- Year-over-year change
- +274.6%
- 4-year CAGR
- +107.8%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 27.01M | +274.6% |
| FY2024 | 2024-12-31 | 7.21M | +24.5% |
| FY2023 | 2023-12-31 | 5.79M | +59.8% |
| FY2022 | 2022-12-31 | 3.62M | +149.9% |
| FY2021 | 2021-12-31 | 1.45M | — |
Other Current Liabilities vs competitors
How IRON compares with its peers on the latest reported figures
- IRON's Sep 2026 other current liabilities of $0 is the 5th highest of the 6 companies compared; the peer median is $16.02M.
- Its year-over-year change of -100.0% is the lowest of 5, against a peer median of +153.6%.
- Other current liabilities amounts to 0.0% of total assets for IRON, versus a peer median of 1.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $30.97M | +23.2% | +91.4% | 5.8% | |
DMRADamora Therapeutics, Inc. | Mar 2026 | $22.03M | +3342.3% | -38.9% | 4.1% |
| Jun 2026 | $16.02M | +220.0% | +46.1% | 1.8% | |
| Mar 2026 | $14.61M | +87.2% | +14.1% | 1.2% | |
IRONDisc Medicine, Inc. | Sep 2026 | $0 | -100.0% | +95.4% | 0.0% |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $0 | — | — | 0.0% |
| Peer median (excluding IRON) | $16.02M | +153.6% | +30.1% | 1.8% | |
Competitors are the stored peer set for IRON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 88.04M | 194.61M | 360.38M | 192.43M | 91.15M |
| Short-term Investments | 0 | 0 | 0 | 297.45M | 700.01M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (802K) | 0 | 0 | 3.73M | 12.75M |
| Total Current Assets | 90.48M | 198.49M | 365.66M | 493.62M | 803.9M |
| Property, Plant & Equipment (Net) | 1.75M | 1.6M | 2.1M | 2.32M | 2.26M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 180K | 116K | 234K | 838K | 726K |
| Total Non-current Assets | 1.93M | 1.71M | 2.33M | 3.16M | 2.98M |
| Total Assets | 92.41M | 200.21M | 368M | 496.77M | 806.88M |
| Account Payables | 2.56M | 16.16M | 12.63M | 7.95M | 9.02M |
| Short-term Debt | 5M | 0 | 0 | 0 | 611K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.45M | 3.62M | 5.79M | 7.21M | 27.01M |
| Total Current Liabilities | 13.42M | 22.58M | 21.44M | 23.32M | 36.64M |
| Long-term Debt | 404K | 0 | 0 | 28.32M | 1.25M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 141.45M | 0 | 0 | 0 | 29.16M |
| Total Non-current Liabilities | 143.19M | 1.03M | 1.44M | 29.87M | 30.41M |
| Total Liabilities | 156.61M | 23.61M | 22.88M | 53.19M | 67.05M |
| Common Stock | 0 | 2K | 2K | 3K | 4K |
| Retained Earnings | (65.39M) | (112.22M) | (188.65M) | (298M) | (510.19M) |
| Accumulated OCI | 0 | 0 | 0 | 289K | 965K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (64.2M) | 176.6M | 345.12M | 443.59M | 739.83M |
| Total Debt | 7.06M | 1.33M | 2.1M | 30M | 1.86M |
| Net Debt | (80.98M) | (193.28M) | (358.28M) | (162.43M) | (89.28M) |
Disc Medicine, Inc.
NASDAQ:IRON
Intrinsic Alpha fair value
Locked
Current Price
$77.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.